BlackRock Submits S-1 Filing for iShares Bitcoin Premium Income ETF

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
According to Bitcoin ETF news, BlackRock filed an S-1 for its iShares Bitcoin Premium Income ETF on January 23, 2026. The product will track Bitcoin's price and generate income through active strategies, including the sale of call options on IBIT shares. This filing marks the first step in the ETF registration process, followed by 19b-4 rule changes and a Nasdaq listing application. ETF news emphasizes the continued effort to provide regulated Bitcoin exposure in the U.S. market.

BlockBeats news: On January 26, Bloomberg ETF analyst Eric Balchunas posted on social media stating that BlackRock has just submitted the official S-1 registration statement for its upcoming iShares Bitcoin Premium Income ETF (filed with the SEC on January 23). The fee and ticker symbol have not yet been disclosed.


The strategy of this product is to track the performance of Bitcoin's price while generating additional income (premium income) through an active management strategy. This is primarily achieved by selling call options based on IBIT shares, and occasionally through operations based on ETP indices.


BlockBeats Note: This S-1 filing is the first step in formally registering the product with the SEC. Next steps may include a 19b-4 rule change and a Nasdaq listing application. Only after approval can the product be officially issued and traded.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.